Other
Obese Patients
0
Pipeline Programs↗
7
Active Trials↗
9
Companies Involved↗
Obese Patients is an early-stage landscape with 0 programs across 9 companies. The most active players are Sanofi, Merck & Co., Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
65
clinical trials
Completed38 · 58%
Unknown status12 · 18%
Recruiting5 · 8%
Terminated5 · 8%
Withdrawn3 · 5%
Not yet recruiting1 · 2%
Other1 · 2%
Clinical Trials
Trial Activity
65 trials
Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients
Recruiting·—·Phase 4·NCT06707012·140 enrolled
Alveolar Recruitment in Obese Patients in Major Gynaecological Cancer Surgery
Recruiting·—·N/A·NCT06619626·40 enrolled
Pharmacodynamic Trial on Rocuronium in Obese Patients
Completed·—·Phase 4·NCT00540085·51 enrolled
Effects of Anesthesia With Propofol Versus Desflurane in Obese Patients
Completed·—·Phase 4·NCT03417518·40 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)